Trinity Biotech plc (TRIB) NASDAQ
0.71
+0.008(+1.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.71
+0.008(+1.15%)
Currency In USD
| Market Cap | 79.02M |
| Enterprise Value | 174.62M |
| P/E Ratio | -0.36 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.15 |
| Price/Book Ratio | -0.24 |
| Enterprise/Revenue | 2.53 |
| Enterprise/EBITDA | -6.66 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.76 |
| Operating Margin | -0.41 |
| Return On Assets | -0.36 |
| Return On Equity | 0.81 |
| Revenue | 61.56M |
| Revenue/Share | 2.61 |
| Gross Profit | 21.44M |
| EBITDA | -16.91M |
| Net Income | -31.79M |
| Diluted EPS | -1.77 |
| Total Cash | 1.34M |
| Total Cash/Share | 0.07 |
| Total Debt | 117.2M |
| Total Debt/Equity | -2.14 |
| Current Ratio | 1.03 |
| Book Value Per Share | -2.93 |
| 52-Week Change | -75.35 |
| 52-Week High | 3.44 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 0.7 |
| Moving Average 200 Days | 0.91 |
| Average Volume | 225,293 |
| Shares Outstanding | 10.39M |
| % Held by Institutions | 4.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | August 27, 2025 |